Gene targeting in ischemic heart disease and failure: Translational and clinical studies

Biochemical Pharmacology

Volumn 85, Issue 1, 2013, Pages 1-11

  Eckhouse, Shaina R ^a,b   Jones, Jeffrey A ^a,b   Spinale, Francis G ^a,b,c,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d WJB Dorn VA Medical Center   (United States)

Author keywords

Adeno associated virus; Adenovirus; Gene therapy; Ischemia; Myocardial infarction; Plasmid

Indexed keywords

ADENOVIRUS VECTOR; FIBROBLAST GROWTH FACTOR 4; LENTIVIRUS VECTOR; LIPOSOME; PARVOVIRUS VECTOR; PLASMID VECTOR; RETROVIRUS VECTOR; VASCULOTROPIN A;

ARTICLE; CORONARY ARTERY; CORONARY VEIN; GENE AMPLIFICATION; GENE EXPRESSION; GENE TARGETING; HEART FAILURE; HEART MUSCLE PERFUSION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

EID: 84871717311     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.08.018     Document Type: Note

References (93)

1. M.A. Konstam, D.G. Kramer, A.R. Patel, M.S. Maron, and J.E. Udelson Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment JACC Cardiovasc Imaging 4 1 2011 98 108 PMID: 21232712
2. M.A. Quiñones, B.H. Greenberg, H.A. Kopelen, C. Koilpillai, M.C. Limacher, and D.M. Shindler Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 35 5 2000 1237 1244 PMID: 10758966
3. H.D. White, R.M. Norris, M.A. Brown, P.W. Brandt, R.M. Whitlock, and C.J. Wild Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction Circulation 76 1 1987 44 51 PMID: 3594774
4. R.A. Weir, J.J. McMurray, and E.J. Velazquez Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance Am J Cardiol 97 10A 2006 13F 25F Epub 2006 Apr 21. PMID: 16698331
5. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 14 2009 e391 e479 Epub 2009 Mar 26. PMID: 19324966
6. M.M. Gaffney, S.O. Hynes, F. Barry, and T. O'Brien Cardiovascular gene therapy: current status and therapeutic potential Br J Pharmacol 152 2 2007 175 188 Epub 2007 Jun 11. PMID: 17558439
7. J.J. Young Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems Rev Cardiovasc Med 8 Suppl. 1 2007 S3 S10 PMID: 17401309
8. A.K. Mitra, and D.K. Agrawal Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology Pharmacogenomics 7 8 2006 1185 1198 PMID: 17184206
9. J.A. Wolff, and V. Budker The mechanism of naked DNA uptake and expression Adv Genet 54 2005 3 20 PMID: 16096005
10. S. Li, M.A. Rizzo, S. Bhattacharya, and L. Huang Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery Gene Ther 5 1998 930 937 PMID: 9813664
11. K. Kawabata, Y. Takakura, and M. Hashida The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake Pharm Res 12 1995 825 830 PMID: 7667185
12. M.S. Al-Dosari, and X. Gao Nonviral gene delivery: principle, limitations, and recent progress AAPS J 11 2009 671 681 PMID: 19834816
13. B.A. French, W. Mazur, R.S. Geske, and R. Bolli Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors Circulation 90 1994 2414 2424 PMID: 7525108
14. J.N. Warnock, C. Daigre, and M. Al-Rubeai Introduction to viral vectors Methods Mol Biol 737 2011 1 25 PMID: 21590391
15. R.W. Atchison, B.C. Casto, and W.M. Hammon Adenovirus-associated defective virus particles Science 149 1965 754 756 PMID: 14325163
16. J.Y. Dong, P.D. Fan, and R.A. Frizzell Quantitative analysis of the packaging capacity of recombinant adeno-associated virus Hum Gene Ther 7 1996 2101 2112 PMID: 8934224
17. W. Xiao, N. Chirmule, S.C. Berta, B. McCullough, G. Gao, and J.M. Wilson Gene therapy vectors based on adeno-associated virus type 1 J Virol 73 1999 3994 4003 PMID: 10196295
18. M.A. Goncalves Adeno-associated virus: from defective virus to effective vector Virol J 2 2005 43
19. B.R. Schultz, and J.S. Chamberlain Recombinant adeno-associated virus transduction and integration Mol Ther 16 2008 1189 1199
20. D.M. McCarty, S.M. Young Jr., and R.J. Samulski Integration of adeno-associated virus (AAV) and recombinant AAV vectors Annu Rev Genet 38 2004 819 845
21. M.G. Kaplitt, X. Xiao, R.J. Samulski, J. Li, K. Ojamaa, and I.L. Klein Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector Ann Thorac Surg 62 1996 1669 1676
22. X. Zhang, and W.T. Godbey Viral vectors for gene delivery in tissue engineering Adv Drug Deliv Rev 58 2006 515 534
23. A.R. Lyon, M. Sato, R.J. Hajjar, R.J. Samulski, and S.E. Harding Gene therapy: targeting the myocardium Heart 94 2008 89 99
24. N.K. Heinzinger, M.I. Bukinsky, S.A. Haggerty, A.M. Ragland, V. Kewalramani, and M.A. Lee The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells Proc Natl Acad Sci USA 91 1994 7311 7315
25. A. Bank, R. Dorazio, and P. Leboulch A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia Ann N Y Acad Sci 1054 2005 308 316
26. A. Chhabra, L. Yang, P. Wang, B. Comin-Anduix, R. Das, and N.G. Chakraborty CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model J Immunol 181 2008 1063 1070
27. D.A. Williams Progress reported in two studies of clinical gene transfer into the retina Mol Ther 16 2008 1181
28. K.A. Horvath, J. Doukas, C-Y.J. Lu, N. Belkind, R. Greene, and G.F. Pierce Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging Ann Thorac Surg 74 2002 481 487
29. A. Jacquier, C.B. Higgins, A.J. Martin, L. Do, D. Saloner, and M. Saeed Injection of adeno-associated viral vector encoding vascular endothelial growth factor gene in infarcted swine myocardium: MR measurements of left ventricular function and strain Radiology 245 2007 196 205
30. C.A. Mack, S.R. Patel, E.A. Schwarz, P. Zanzonico, R.T. Hahn, and A. Ilercil Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart J Thorac Cardiovasc Surg 115 1998 168 177
31. T. Pätilä, T. Ikonen, J. Rutanen, A. Ahonen, J. Lommi, and K. Lappalainen Vascular endothelial growth factor C-induced collateral formation in a model of myocardial ischemia J Heart Lung Transplant 25 2006 206 213
32. M.J. Post, K. Sato, M. Murakami, J. Bao, D. Tirziu, and J.D. Pearlman Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation Am J Physiol Regul Integr Comp Physiol 290 2006 R494 R500
33. J. Rutanen, T.T. Rissanen, J.E. Markkanen, M. Gruchala, P. Silvennoinen, and A. Kivela Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart Circulation 109 2004 1029 1035
34. P.R. Vale, D.W. Losordo, T. Tkebuchava, D. Chen, C.E. Milliken, and J.M. Isner Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping J Am Coll Cardiol 34 1999 246 254
35. P.R. Vale, D.W. Losordo, C.E. Milliken, M.C. McDonald, L.M. Gravelin, and C.M. Curry Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia Circulation 103 2001 2138 2143
36. M.H. Gao, N.C. Lai, M.D. McKirnan, D.A. Roth, G.M. Rubanyi, and N. Dalton Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4: report of preclinical data Hum Gene Ther 15 2004 574 587
37. F.J. Giordano, P. Ping, M.D. McKirnan, S. Nozaki, A.N. DeMaria, and W.H. Dillmann Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart Nat Med 2 1996 534 539
38. G. Suzuki, T.C. Lee, J.A. Fallavollita, and J.M. Canty Jr. Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle Circ Res 96 2005 767 775
39. M. Laitinen, J. Hartikainen, M.O. Hiltunen, J. Eranen, M. Kiviniemi, and O. Narvanen Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty Hum Gene Ther 11 2000 263 270
40. P. Boekstegers, G. von Degenfeld, W. Giehrl, D. Heinrich, R. Hullin, and C. Kupatt Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins Gene Ther 7 2000 232 240
41. P. Raake, G. von Degenfeld, R. Hinkel, R. Vachenauer, T. Sandner, and S. Beller Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery J Am Coll Cardiol 44 2004 1124 1129
42. M. Ferrarini, N. Arsic, F.A. Recchia, L. Zentilin, S. Zacchigna, and X. Xu Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs Circ Res 98 2006 954 961
43. J.S. Choi, K.B. Kim, W. Han, D.S. Kim, J.S. Park, and J.J. Lee Efficacy of therapeutic angiogenesis by intramyocardial injection of pCK-VEGF165 in pigs Ann Thorac Surg 82 2006 679 686
44. R.A. Tio, T. Tkebuchava, T.H. Scheuermann, C. Lebherz, M. Magner, and M. Kearny Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium Hum Gene Ther 10 1999 2953 2960
45. B.A. French, W. Mazur, N.M. Ali, R.S. Geske, J.P. Finnigan, and G.P. Rodgers Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis Circulation 90 1994 2402 2413
46. D.W. Losordo, P.R. Vale, J.F. Symes, C.H. Dunnington, D.D. Esakof, and M. Maysky Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 1998 2800 2804
47. J.F. Symes, D.W. Losordo, P.R. Vale, K.G. Lathi, D.D. Esakof, and M. Mayskiy Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease Ann Thorac Surg 68 1999 830 836 discussion 6-7
48. Y.D. Lin, C.Y. Luo, Y.N. Hu, M.L. Yeh, Y.C. Hsueh, and M.Y. Chang Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair Sci Transl Med 4 146 2012 146ra109 PMID: 22875829
49. C. Sylven, N. Sarkar, A. Ruck, V. Drvota, S.Y. Hassan, and B. Lind Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A165 plasmid in patients with inoperable angina pectoris Coron Artery Dis 12 2001 239 243
50. N. Sarkar, A. Rück, G. Källner, S. Y-Hassan, P. Blomberg, and K.B. Islam Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease-12-month follow-up: angiogenic gene therapy J Intern Med 250 2001 373 381
51. F.D. Fortuin, P. Vale, D.W. Losordo, J. Symes, G.A. DeLaria, and J.J. Tyner One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients Am J Cardiol 92 2003 436 439
52. D.W. Losordo, P.R. Vale, R.C. Hendel, C.E. Milliken, F.D. Fortuin, and N. Cummings Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia Circulation 105 2002 2012 2018
53. J. Kastrup, E. Jørgensen, A. Rück, K. Tägil, D. Glogar, and W. Ruzyllo Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo-controlled study: The Euroinject One trial J Am Coll Cardiol 45 2005 982 988
54. R.S. Ripa, Y. Wang, E. Jorgensen, H.E. Johnsen, B. Hesse, and J. Kastrup Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease Eur Heart J 27 2006 1785 1792
55. D.J. Stewart, M.J. Kutryk, D. Fitchett, M. Freeman, N. Camack, and Y. Su VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial Mol Ther 17 2009 1109 1115
56. T.K. Rosengart, L.Y. Lee, S.R. Patel, P.D. Kligfield, P.M. Okin, and N.R. Hackett Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA Ann Surg 230 1999 466 470
57. C.L. Grines, M.W. Watkins, G. Helmer, W. Penny, J. Brinker, and J.D. Marmur Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris Circulation 105 2002 1291 1297
58. C.L. Grines, M.W. Watkins, J.J. Mahmarian, A.E. Iskandrian, J.J. Rade, and P. Marrott A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina J Am Coll Cardiol 42 2003 1339 1347
59. M. Hedman, J. Hartikainen, M. Syvanne, J. Stjernvall, A. Hedman, and A. Kivela Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT) Circulation 107 2003 2677 2683
60. D.J. Stewart, J.D. Hilton, J.M.O. Arnold, J. Gregoire, A. Rivard, and S.L. Archer Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment Gene Ther 13 2006 1503 1511
61. T.D. Henry, C.L. Grines, M.W. Watkins, N. Dib, G. Barbeau, and R. Moreadith Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials J Am Coll Cardiol 50 2007 1038 1046
62. M.J. Byrne, J.M. Power, A. Preovolos, J.A. Mariani, R.J. Hajjar, and D.M. Kaye Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals Gene Ther 15 2008 1550 1557
63. F. del Monte, S.E. Harding, U. Schmidt, T. Matsui, Z.B. Kang, and G.W. Dec Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a Circulation 100 1999 2308 2311
64. F. del Monte, D. Lebeche, J.L. Guerrero, T. Tsuji, A.A. Doye, and J.K. Gwathmey Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling Proc Natl Acad Sci USA 101 2004 5622 5627
65. R.J. Hajjar, K. Zsebo, L. Deckelbaum, C. Thompson, J. Rudy, and A. Yaroshinsky Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure J Card Fail 14 2008 355 367
66. B.E. Jaski, M.L. Jessup, D.M. Mancini, T.P. Cappola, D.F. Pauly, and B. Greenberg Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial J Card Fail 15 2009 171 181
67. Y. Kawase, H.Q. Ly, F. Prunier, D. Lebeche, Y. Shi, and H. Jin Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure J Am Coll Cardiol 51 2008 1112 1119
68. D.M. Kaye, A. Preovolos, T. Marshall, M. Byrne, M. Hoshijima, and R. Hajjar Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals J Am Coll Cardiol 50 2007 253 260
69. M. Jessup, B. Greenberg, D. Mancini, T. Cappola, D.F. Pauly, and B. Jaski Calcium upregulation by percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) investigators. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure Circulation 124 3 2011 304 313 Epub 2011 Jun 27. PMID: 21709064
70. H. Brinks, D. Rohde, M. Voelkers, G. Qiu, S.T. Pleger, and N. Herzog S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes J Am Coll Cardiol 58 9 2011 966 973 PMID: 21851887
71. S.T. Pleger, C. Shan, J. Ksienzyk, R. Bekeredjian, P. Boekstegers, and R. Hinkel Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model Sci Transl Med 3 92 2011 92ra64 PMID: 21775667
72. D. Rohde, J. Ritterhoff, M. Voelkers, H.A. Katus, T.G. Parker, and P. Most S100A1: a multifaceted therapeutic target in cardiovascular disease J Cardiovasc Transl Res 3 5 2010 525 537 Epub 2010 Jul 20. PMID: 20645037
73. Z.M. Huang, J.I. Gold, and W.J. Koch G protein-coupled receptor kinases in normal and failing myocardium Front Biosci 16 Jun 2011 3047 3060 PMID: 21622221
74. J. Reinkober, H. Tscheschner, S.T. Pleger, P. Most, H.A. Katus, and W.J. Koch Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade Gene Ther 19 6 2012 686 693 10.1038/gt.2012.9 Epub 2012 Feb 16. PMID: 22336718
75. G. Rengo, A. Lymperopoulos, D. Leosco, and W.J. Koch GRK2 as a novel gene therapy target in heart failure J Mol Cell Cardiol 50 5 2011 785 792 Epub 2010 Aug 25. PMID: 20800067
76. H.M. Phan, M.H. Gao, N.C. Lai, T. Tang, and H.K. Hammond New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy Trends Cardiovasc Med 17 7 2007 215 221 PMID: 17936202
77. N.C. Lai, D.M. Roth, M.H. Gao, T. Tang, N. Dalton, and Y.Y. Lai Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure Circulation 110 3 2004 330 336 Epub 2004 Jul 12. PMID: 15249510
78. H. Ly, Y. Kawase, R. Yoneyama, and R.J. Hajjar Gene therapy in the treatment of heart failure Physiology (Bethesda) 22 Apr 2007 81 96 PMID: 17420300
79. H.K. Kammond, W. Perry, and T.D. Henry Clinical trial Ad5.hAC6 gene transfer for CHF 2011 NCT00787059
80. Y.J. Meir, and S.C. Wu Transposon-based vector systems for gene therapy clinical trials: challenges and considerations Chang Gung Med J 34 6 2011 565 579 PMID: 22196059
81. Z. Ivics, M.A. Li, L. Mátés, J.D. Boeke, A. Nagy, and A. Bradley Transposon-mediated genome manipulation in vertebrates Nat Methods 6 6 2009 415 422 PMID: 19478801
82. P.B. Hackett, D.A. Largaespada, and L.J. Cooper A transposon and transposase system for human application Mol Ther 18 4 2010 674 683 Epub 2010 Jan 26. PMID: 20104209
83. Z. Ivics, P.B. Hackett, R.H. Plasterk, and Z. Izsvák Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells Cell 91 4 1997 501 510 PMID: 9390559
84. E.L. Ayuni, A. Gazdhar, M.N. Giraud, A. Kadner, M. Gugger, and M. Cecchini In vivo electroporation mediated gene delivery to the beating heart PLoS One 5 12 2010 e14467 PMID: 21209934
85. R.V. Shohet, S. Chen, Y.T. Zhou, Z. Wang, R.S. Meidell, and R.H. Unger Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium Circulation 101 22 2000 2554 2556 PMID: 10840004
86. E.L. Aronovich, R.S. McIvor, and P.B. Hackett The Sleeping Beauty transposon system: a non-viral vector for gene therapy Hum Mol Genet 20 R1 2011 R14 R20 Epub 2011 Apr 1. PMID: 21459777
87. H. Nakanishi, Y. Higuchi, S. Kawakami, F. Yamashita, and M. Hashida piggyBac transposon-mediated long-term gene expression in mice Mol Ther 18 4 2010 707 714 Epub 2010 Jan 26. PMID: 20104210
88. E. Belay, J. Mátrai, A. Acosta-Sanchez, L. Ma, M. Quattrocelli, and L. Mátés Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: a nonviral paradigm for coaxed differentiation Stem Cells 28 10 2010 1760 1771 PMID: 20715185
89. T. VandenDriessche, Z. Ivics, Z. Izsvák, and M.K. Chuah Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells Blood 114 8 2009 1461 1468 Epub 2009 May 26. PMID: 19471016
90. L. Liu, S. Sanz, A.D. Heggestad, V. Antharam, L. Notterpek, and B.S. Fletcher Endothelial targeting of the Sleeping Beauty transposon within lung Mol Ther 10 1 2004 97 105 PMID: 15233946
91. L. Liu, H. Liu, G. Visner, and B.S. Fletcher Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats FASEB J 20 14 2006 2594 2596 Epub 2006 Oct 25. PMID: 17065228
92. T.I. Orbán, A. Apáti, A. Németh, N. Varga, V. Krizsik, and A. Schamberger Applying a double-feature promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery Stem Cells 27 5 2009 1077 1087 PMID: 19415778
93. S.R. Yant, A. Ehrhardt, J.G. Mikkelsen, L. Meuse, T. Pham, and M.A. Kay Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo Nat Biotechnol 20 10 2002 999 1005 Epub 2002 Sep 16. PMID: 12244327